Previous Page  11 / 59 Next Page
Information
Show Menu
Previous Page 11 / 59 Next Page
Page Background

ENZALUTAMIDE HAS PROVED SURVIVAL BENEFIT IN 1ST & 2ND LINES IN MCRPC

Scher HI, et al. N Engl J Med 2012;367(13):1187-97

Beer TM, et al. N Engl J Med 2014;371:424-33